Best EU Biotech Podcasts (2026)

1
This Month in German, Swiss and Austrian Startups - December 2025 Deep Dive 23:55

Play Pause

8d ago23:55

23:55

A decision-grade map of DACH execution signals for 2026: where regulation creates demand, where AI credibility is earned, and which business models are being repriced. This episode breaks down what actually changed in the DACH startup ecosystem heading into 2026. - Europe's AI advantage in regulated and industrial applications - Why integration and…

1
DACH Startup Ecosystem 2026: AI Mega-Rounds, Dual Use & Europe's New Venture Stack

14d ago

—

The DACH startup ecosystem closed 2025 with unusually clear signals for 2026 — AI mega-rounds, defense-grade dual use, and a restructuring of Europe’s venture capital stack. What you’ll learn in this episode: – Why €3B AI valuations change Europe’s startup narrative – How dual use moved from story to category – What founders must understand about c…

1
Back on Signal

15d ago

—

A short update on our publishing schedule. A technical issue caused a brief pause — all content is safe, and we’re back to regular releases from here. 🚪 Connect with Us Partner with us: [email protected] Subscribe: https://linktr.ee/startupradio Feedback: https://forms.gle/SrcGUpycu26fvMFE9 Follow Joe on LinkedIn: http://www.linkedin.com/c…

1
How Tumor-on-a-Chip Technology Is Transforming Cancer Treatment and Drug Testing

19d ago

—

What if the tools we use to test cancer drugs don’t behave like human tumors at all? That’s the question that pushed Ghazaleh Madani, CEO and co-founder of CanChips, to build one of the most compelling innovations in oncology today: tumor-on-a-chip platforms that replicate human tumor biology with unprecedented accuracy. In this episode, we explore…

1
The scramble for hydrogen in South Africa 32:13

14d ago32:13

32:13

In this episode, Joana and Pascoe, co-directors of Corporate Europe Observatory's new documentary "The scramble for hydrogen in South Africa" talk about the process behind the making of the film. It's a more relaxed and informal episode than usual, where you can get to know the whole truth behind the making of the film, and how you can host your ve…

1
German Startup Ecosystem 2025: AI Becomes Infrastructure & DeepTech Booms 34:00

26d ago34:00

34:00

AI is no longer the shiny object. It’s becoming infrastructure. And that single shift is transforming the German startup ecosystem in 2025 faster than most founders expected. This month, the DACH region crossed a new threshold: AI is moving from hype into the industrial backbone of Europe — compute scarcity is now strategic, sovereign cloud has bec…

1
Werner Lanthaler 🇦🇹 | Biopharma AI, CDMO, Antibody Optimization | E48 59:34

24d ago59:34

59:34

1
At What Cost? The EU’s Race for Critical Raw Materials in the Global South 18:37

28d ago18:37

18:37

In this episode, Isabela Franco and Lora Verheecke from Counter Balance unpack the EU’s growing push for critical raw materials and its implications for the Global South. They discuss the Global Gateway, the Critical Raw Materials Act, the use of public funds to “de-risk” private investments and the lack of meaningful participation for impacted com…

1
European Tech Sovereignty: The November 2025 DACH Startup News Briefing 22:25

1M ago22:25

22:25

Europe's startup narrative is changing fast — from apps and valuations to sovereignty, infrastructure and resilience. In this month's DACH Startup News, we unpack the moves that made European tech sovereignty the defining theme of 2025. What you’ll learn: – Why sovereign cloud is becoming foundational for startups and enterprise buyers – How AI, ro…

1
Camel Startups: How Capital-Efficient Founders Scale in the DACH Region 19:36

1M ago19:36

19:36

What if you could build a startup that survives downturns, grows profitably, and never depends on constant fundraising? That’s the core of the camel startup strategy — and in this episode, STS Ventures investor Stephan Schubert breaks it down with 25+ years of operator-investor experience. From founding OnVista in the early internet era to backing …

1
Thomas Lingelbach, Valneva | Vaccines, Lyme Disease | E47 44:27

1M ago44:27

44:27

Valneva now has three commercialized vaccines, and a Lyme disease candidate in Phase 3. Philip quizzes CEO Thomas Lingelbach about everything. They also discuss the current political turbulence with vaccines, especially in the US, and how it is impacting the industry.⭐️ ABOUT THE SPEAKERA veteran in the development of more than ten vaccines, Thomas…

1
AI Agents Are the New Attackers — Inside the Identity Security Platform Built for 2025 40:41

1M ago40:41

40:41

What if the biggest cyber risk inside your company wasn’t malware — but identity? In this episode, I sit down with Santhosh Jayaprakash, founder & CEO of UnoSecur, to unpack one of the fastest-moving transformations in cybersecurity: the rise of identity as the new perimeter. Attackers don’t break in anymore — they log in. And with AI agents, LLM w…

1
Marc de Garidel, Abivax 🇫🇷 | Ulcerative Colitis, Inflammation | E46 53:40

1M ago53:40

53:40

When Abivax released stunning phase 3 results for ulcerative colitis, its 600% stock price surge froze Euronext for 45 minutes. Philip meets Abivax CEO Marc de Garidel in Vienna, Austria, to go behind the scenes of a remarkable biotech turnaround. Marc discusses the processes involved in executing the phase 3 trial that beat even Abivax’s own phase…

1
The AI Agents That Give Craftsmen Their Weekends Back | PlanCraft's €38M Story 38:52

2M ago38:52

38:52

What if AI could give craftsmen their time back? In this episode of Startuprad.io, host Jörn Menninger sits down with Julian Wiedenhaus, CEO and Co-Founder of PlanCraft, to explore how AI agents and voice interfaces are reshaping Europe’s construction sector. From a family carpentry shop to a €38 M Series B, PlanCraft built an AI-first SaaS that he…

1
There are now more Big Tech lobbyists than MEPs 15:57

2M ago15:57

15:57

Do you know how much money Big Tech is spending on lobbying in Brussels? How has this amount been increasing? On what is the money being funnelled to and what can we do about it? Listen to our new episode of the podcast EU Watchdog Radio to find out!

1
Laurent Levy, Nanobiotix 🇫🇷 | Nanoparticles, Radiotherapy | E45 50:03

2M ago50:03

50:03

As Philip travels to France, Nanobiotix CEO Laurent Lévy discusses how the company broke into Europe’s exclusive $1 billion biotech club, alongside the likes of Abivax and Medincell. They also chat about what it means to partner with giants like Johnson & Johnson, and how Laurent’s leadership style has evolved over his long tenure. ⭐️ ABOUT THE SPE…

1
How Edurino Built Europe’s Hybrid Learning Revolution for Kids 40:23

2M ago40:23

40:23

Can “screen time” actually make kids smarter? That’s the question Irene Klemm, Co-Founder and Co-CEO of Edurino, set out to answer — and in doing so, built one of Europe’s fastest-growing edtech startups. From lockdown chaos to scaling across the DACH region and the UK, Irene shares how Edurino redefined hybrid learning for kids by combining physic…

1
October 2025 Deep Dive – AI Startups, Venture Capital & Fintech in DACH 25:56

2M ago25:56

25:56

🏁 The Deep Dive is here. Germany, Austria and Switzerland enter a new startup cycle where the headline isn’t “Who raised the biggest check?” but “Who’s building the most defensible foundation?” Hosts Jörn ‘Joe’ Menninger and Chris Fahrenbach break down October 2025’s most important stories in AI, fintech, venture capital, and climate tech. 🔎 What Y…

1
Green Hydrogen or Green Colonialism? 16:03

2M ago16:03

16:03

In this episode, Lora Verheecke, Policy Officer at Counter Balance, interviewed Hikma Bachegour, an Assistant Professor in the Sidi Mohamed Ben Abdellah University in Fez, Morocco. They highlighted the impacts of European hydrogen projects in Morocco and how it could affect vulnerable communities, women, and gender minorities, who are too often lef…

1
Europe’s AI Supercluster: How DACH Startups Are Outpacing Silicon Valley 26:35

2M ago26:35

26:35

What if Europe — not Silicon Valley — defined the future of AI? In this October 2025 episode of Startuprad.io Startup News, hosts Jörn “Joe” Menninger and Chris Fahrenbach break down the latest stories shaping Europe’s AI Supercluster, led by DeepL, Black Forest Labs, and N8N. From record climate tech funding to biotech breakthroughs and industrial…

1
Gerrit Sitters, LUMICKS 🇳🇱 | CAR-T therapy, Single-Cell Analysis | E44 [Sponsored] 1:24:33

2M ago1:24:33

1:24:33

As Philip tours Amsterdam, he visits the biotech tools startup LUMICKS. Founded in 2014, the firm offers products analyzing the binding interactions between molecules and cells, with applications in drug development, CAR-T therapies, and manufacturing. Philip sits down with co-founder Gerrit Sitters to discuss the company’s trajectory, the cyclic b…

1
New season coming soon! 0:48

2M ago0:48

0:48

Stay tuned to a brand new season of EU Watchdog Radio, where new hosts Isabela Franco and Lora Verheecke from Counter Balance join Marcella Via and Joana Louçã from Corporate Europe Observatory. New episodes coming soon!

1
How Xaver Lehmann Recovered from Burnout After a $60 M Startup Exit 58:52

2M ago58:52

58:52

He sold his AI startup for $60 million — and fell apart. In this raw and powerful conversation, Xaver Lehmann, co-founder and former CEO of e-bot7, opens up about burnout, loss, and recovery after one of Europe’s biggest AI exits. What happens when you achieve everything you ever wanted — and it breaks you? 💡 What you’ll learn in this episode: – Ho…

1
Fabrice Chouraqui, Pharming 🇳🇱 | Transgenic Rabbits, Rare Diseases | E43 54:48

2M ago54:48

54:48

We travel to the offices of Pharming Group in Leiden, the Netherlands, to chat with the newcomer CEO Fabrice Chouraqui. Fabrice discusses the fascinating history of Pharming, with its first commercial drug RUCONEST produced in the milk of transgenic rabbits. He also talks about the growth of Pharming from a protein therapy-focused biotech into a Eu…

1
It’s a Brave New World: Pharma ad/promo enforcement is changing in the U.S. and Europe, and companies should, too 26:21

2M ago26:21

26:21

FDA’s recent splash of 100+ enforcement letters objecting to drug advertising looks like a trend, not a blip. And although the UK and EU prohibit DTC ads for Rx drugs, there are new efforts creating risk for pharma companies, even if they’re not the main focus. In this episode of Talking the Cure, host Phil Katz is joined by Heidi Gertner, Sally Gu…

1
Flow State Rituals for Founders: Deep Work, Distraction Hacks & AI Focus 47:44

3M ago47:44

47:44

In this episode, Steven Puri, CEO of The Sukha Company and former Hollywood VFX executive (Independence Day, Godzilla, Transformers Prime), shares the rituals, behavioral frameworks, and AI-powered systems he uses to help founders reach deep work in distraction-heavy environments. Steven’s journey from blockbuster sets to startup leadership reveals…

1
Daniela Marino, CUTISS 🇨🇭 | Tissue Engineering, Skin Grafts | E42 [Sponsored] 1:07:40

2M ago1:07:40

1:07:40

Hot on the heels of CUTISS’ $60M Series C round, we catch up once more with CEO and co-founder Daniela Marino. We chat about the company’s mission to develop an engineered tissue therapy to reduce the need for skin grafts in patients with severe burns. She also explains the decentralization of tissue manufacturing with automation and the need for p…

1
Flow State for Startup Founders: Deep Work That Actually Ships 51:12

3M ago51:12

51:12

Steven Puri, co-founder/CEO of Sukha, shares the flow state for startup founders playbook: body doubling, the coffee-shop effect, chronotype time-blocking, demo-first standups, and outcome-based leadership. You’ll learn how to beat the 22-minute context switching tax, design deep-work rituals for remote teams, and build a best-idea-wins culture tha…

1
Dragan Grabulovski, Araris 🇨🇭 | ADC Linkers, Replacing Chemotherapy | E41 1:08:49

3M ago1:08:49

1:08:49

Philip meets up with Dragan Grabulovski, CEO of the startup Araris, at Lake Zurich to chat about the company’s work with antibody-drug conjugates (ADCs).They talk about Araris’ huge $400M upfront buyout by Taiho Pharma of Japan, Dragan’s extensive history as a biotech entrepreneur, and Araris’ vision to replace chemotherapy with ADCs.⭐️ ABOUT THE S…

1
German Startup News Sept 2025: Deep Tech, VC Surge, Fintech & Big Fundings 21:32

3M ago21:32

21:32

In this September 2025 wrap-up, hosts Jörn “Joe” Menninger and Chris Fahrenbach break down the signals that actually matter for B2B operators: where capital is flowing, how deep tech is commercializing, and what shifting regulatory winds mean for product, go-to-market, and hiring. Expect fast, factual coverage of German startups, Swiss and Austrian…

1
German Startup News Sept 2025: $2.3B AI Unicorn, N26 Crisis & Climate Tech 21:32

3M ago21:32

21:32

Berlin’s AI unicorn skyrocketed from $350M to $2.3B in valuation in just months. Meanwhile, fintech giant N26 faces its most severe governance crisis yet, as its co-founder CEO steps down after regulatory pressure. And Europe’s climate tech sector is booming with mega-funding rounds, including a record €825M hydrogen allocation. This is your Septem…

1
Stefano Portolano, Azafaros 🇳🇱 🇨🇭 | Rare Diseases, Small Molecules | E40 1:18:34

3M ago1:18:34

1:18:34

On a trip to Basel, Switzerland, Philip catches up with Stefano Portolano, CEO of the European firm Azafaros. They chat about Azafaros’ massive $147M Series B round in May 2025, which is being used to develop a small molecule treatment for rare diseases known as lysosomal storage disorders.Stefano also explains how rare diseases went in and out of …

1
Global Emissions Surveillance & Digital Product Passports

3M ago

—

Climate TRACE tracks emissions from over 660 million sources in near real-time. That data is already flowing into supply chains, digital product passports, and carbon scoring systems, enabling enforcement on farmers, landowners, and consumers. This video breaks down the architecture of control that’s already live. Download (mp3): Support: https://u…